SEC Comment Letter for Theriva Biologics, Inc. (TOVX) (CIK 0000894158) (TOVX) — Mar 1, 2011

Theriva Biologics, Inc. (TOVX) (CIK 0000894158)
Date: March 1, 2011 · CIK: 0000894158 · Accession: 0000000000-11-012902

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

February 24, 2011

Author

Melissa N. Rocha

Form

UPLOAD

Company

Theriva Biologics, Inc. (TOVX) (CIK 0000894158)

Letter

Re: Adeona Pharmaceuticals, Inc. Form 10- K for the Year Ended December 31, 2009 Form 10- Q for the Interim Period Ended June 30, 2010 File No. 001 -12584 Dear Mr. Kuo :

February 24, 2011

Mr. James S. Kuo, M.D., M.B.A President and Chief Executive Officer Adeona Pharmaceuticals, Inc. 3930 Varsity Drive Ann Arbor, MI 48108

We have completed our review of the above referenced filings and have no further comments at this time.

Sincerely,
Melissa N. Rocha
Branch Chief

Show Raw Text

February 24, 2011

Mr. James S. Kuo, M.D., M.B.A
President and Chief Executive Officer
Adeona Pharmaceuticals, Inc.
3930 Varsity Drive
Ann Arbor, MI  48108

Re: Adeona Pharmaceuticals, Inc.
Form 10- K for the Year Ended December 31, 2009
Form 10- Q for the Interim Period Ended June 30, 2010
File No. 001 -12584
 Dear Mr. Kuo :

 We have completed our review of the above referenced filings and have no further
comments at this time.

Sincerely,

  Melissa N. Rocha
Branch Chief

SecProbe.io